Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review
Marco Solmi,1,2 Andrea Murru,3 Isabella Pacchiarotti,3 Juan Undurraga,4,5 Nicola Veronese,2,6 Michele Fornaro,7,8 Brendon Stubbs,2,9–11 Francesco Monaco,2 Eduard Vieta,3 Mary V Seeman,12 Christoph U Correll,13,14 André F Carvalho2,15 1Neuroscience Department, University of Padua...
Saved in:
Main Authors: | Solmi M (Author), Murru A (Author), Pacchiarotti I (Author), Undurraga J (Author), Veronese N (Author), Fornaro M (Author), Stubbs B (Author), Monaco F (Author), Vieta E (Author), Seeman MV (Author), Correll CU (Author), Carvalho AF (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Second-generation antipsychotic and diabetes mellitus in children and adolescents
by: Carlo Ripoli, et al.
Published: (2017) -
Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia
by: Giuseppe Caruso, et al.
Published: (2020) -
Treatment of tardive dyskinesia with VMAT-2 inhibitors: a systematic review and meta-analysis of randomized controlled trials
by: Solmi M, et al.
Published: (2018) -
Antipsychotics, Hypothermia, Undressing, and Death
by: Mary V Seeman
Published: (2017) -
Metabolic consequences of second-generation antipsychotics in youth: appropriate monitoring and clinical management
by: Krill RA, et al.
Published: (2014)